1. Home
  2. PTCT vs SYM Comparison

PTCT vs SYM Comparison

Compare PTCT & SYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$63.51

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Logo Symbotic Inc.

SYM

Symbotic Inc.

SELL

Current Price

$40.92

Market Cap

5.5B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
PTCT
SYM
Founded
1998
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.5B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
PTCT
SYM
Price
$63.51
$40.92
Analyst Decision
Buy
Buy
Analyst Count
14
17
Target Price
★ $101.07
$62.86
AVG Volume (30 Days)
1.2M
★ 1.5M
Earning Date
11-03-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 264.48
N/A
EPS
★ 0.90
0.12
Revenue
$264,734,000.00
★ $2,246,922,000.00
Revenue This Year
N/A
$24.67
Revenue Next Year
$9.26
$29.40
P/E Ratio
★ $71.38
$357.29
Revenue Growth
★ 36.19
25.65
52 Week Low
$61.23
$37.68
52 Week High
$90.87
$87.88

Technical Indicators

Market Signals
Indicator
PTCT
SYM
Relative Strength Index (RSI) 40.49 43.63
Support Level $62.46 $39.15
Resistance Level $72.86 $44.73
Average True Range (ATR) 2.00 1.44
MACD 0.19 -0.21
Stochastic Oscillator 38.57 1.31

Price Performance

Historical Comparison
PTCT
SYM

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About SYM Symbotic Inc.

Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.

Share on Social Networks: